Longitudinal trajectory of thoracic CTA-derived sarcopenia stratifies mortality risk in transcatheter aortic valve
Yi Zhang1, Tianying Zheng2, Yanjiani Xu3
1Department of Cardiology, West China Hospital, Sichuan University, No.37 Guoxue Street, Chengdu 610041, PR China; Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, PR China; Cardiac Structure and Function Research Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Background:
Although sarcopenia is a known predictor of outcomes in cardiovascular diseases, its disease trajectory, including improvement, stability, or worsening, following transcatheter aortic valve replacement (TAVR) remains insufficiently explored. This study pioneered using pectoralis muscle index (PMI) from routine thoracic computed tomography angiography (CTA) to track sarcopenia changes post-TAVR and determine prognostic value.
Methods:
This single-center cohort included consecutive TAVR patients with serial thoracic CTA at baseline and 1 year. PMI was calculated as pectoralis muscle area at the fourth thoracic vertebra normalized to height2. Using sex-specific PMI thresholds, patients were stratified into four phenotypes: non-sarcopenic, early-onset, late-onset, or persistent sarcopenia. Multivariate Cox regression identified mortality predictors.
Results:
Among 258 patients (median age 72.86; 56.59% male), both baseline PMI (median 1,067.19 mm2/m2, p = 0.038) and 1-year PMI (median 1,145.95 mm2/m2, p = 0.016) independently predicted survival during a median 1,495-day follow-up (mortality 12.79%). Compared to non-sarcopenic patients, those with persistent sarcopenia (17.83% of cohort) had significantly elevated mortality risk (Hazard ratio = 3.94, 95% CI = 1.44-10.80, p = 0.008).
Conclusions:
This study suggests the potential of PMI quantification via thoracic CTA as a clinically integrable tool for prognostic stratification in TAVR recipients through sarcopenia monitoring, which warrants further randomized investigation for potential generalization to other cardiac interventions. The identification of persistent sarcopenia as a modifiable risk factor mandates the implementation of protocolized nutritional optimization and structured rehabilitation programs in high-risk subgroups.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:28Imaging Studies for Cardiovascular System V: CT
01:10Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
01:15Thoracic Aorta
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...